Valuation: SSY Group Limited

Market Cap 7.16B 913M 782M 732M 670M 1.26B 87.33B 1.27B 8.64B 3.37B 43.87B 3.43B 3.35B 145B P/E 2026 *
12.7x
P/E 2027 * 10.3x
Enterprise Value 7.16B 913M 782M 732M 670M 1.26B 87.33B 1.27B 8.64B 3.37B 43.87B 3.43B 3.35B 145B EV / Sales 2026 *
1.47x
EV / Sales 2027 * 1.31x
Free-Float
33.48%
Yield 2026 *
4.04%
Yield 2027 * 4.44%
1 day-0.61%
1 week+2.07%
Current month+3.36%
1 month+2.50%
3 months+4.68%
6 months-15.17%
Current year-13.07%
1 week 2.38
Extreme 2.385
2.55
1 month 2.36
Extreme 2.36
2.55
Current year 2.01
Extreme 2.01
3.15
1 year 2.01
Extreme 2.01
3.4
3 years 2.01
Extreme 2.01
5.2
5 years 2.01
Extreme 2.01
5.68
10 years 2.01
Extreme 2.01
9.46
Manager TitleAgeSince
Chief Executive Officer 69 23/03/2010
Director of Finance/CFO 45 01/04/2015
Corporate Officer/Principal 42 28/08/2024
Director TitleAgeSince
Chairman 69 04/06/2014
Director/Board Member 61 26/07/2007
Director/Board Member 57 16/10/2005
Date Insider Type Main position Quantity % Market Cap.
09/01/26 Other

Chief Executive Officer

456,000 0.0155%
08/01/26 Other

Chief Executive Officer

1,486,000 0.0504%
07/01/26 Other

Chief Executive Officer

1,128,000 0.0382%
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+2.07%-20.65%-39.11% 913M
+0.88%+6.38%+76.40%+126.87% 1,119B
+1.07%+3.80%+50.73%+64.25% 651B
+1.20%+6.21%+25.81%+80.15% 468B
-1.13%+5.77%+43.63%+43.06% 374B
-0.67%+4.07%+24.97%+41.00% 302B
-1.01%+6.81%+2.27%+13.65% 259B
+1.88%+5.81%+49.57%+70.71% 238B
-0.33%+2.09%-17.33%-53.85% 208B
+1.87%+5.61%+27.32%+89.67% 181B
Average +0.32%+4.95%+26.27%+43.64% 380.08B
Weighted average by Cap. +0.55%+5.39%+44.25%+72.40%

Financials

2026 *2027 *
Net sales 4.88B 622M 533M 499M 456M 857M 59.52B 868M 5.89B 2.3B 29.9B 2.34B 2.29B 98.9B 5.47B 698M 598M 560M 512M 961M 66.79B 974M 6.61B 2.58B 33.55B 2.62B 2.56B 111B
Net income 587M 74.88M 64.14M 60.02M 54.94M 103M 7.16B 104M 709M 277M 3.6B 281M 275M 11.9B 702M 89.48M 76.65M 71.72M 65.65M 123M 8.56B 125M 847M 330M 4.3B 336M 329M 14.23B
Net Debt - -
Logo SSY Group Limited
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Employees
5,472
Date Price Change Volume
24/08/26 HK$2.465 -0.40% 5,268,000
21/08/26 HK$2.475 +1.23% 2,578,000
20/08/26 HK$2.445 +1.87% 10,526,000
19/08/26 HK$2.400 -0.62% 2,658,000
18/08/26 HK$2.415 +0.21% 2,090,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.475HKD
Average target price
3.640HKD
Spread / Average Target
+47.07%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2005 Stock